New mitochondrial DNA synthesis enables NLRP3 inflammasome activation-Reference-Cited by-同舟云学术

New mitochondrial DNA synthesis enables NLRP3 inflammasome activation

Published:2018-07-25 Issue:7717 Volume:560 Page:198-203
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Zhong Zhenyu,Liang Shuang,Sanchez-Lopez Elsa,He Feng,Shalapour Shabnam,Lin Xue-jia,Wong Jerry,Ding Siyuan,Seki Ekihiro,Schnabl Bernd,Hevener Andrea L.,Greenberg Harry B.,Kisseleva Tatiana,Karin Michael

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-018-0372-z.pdf

Reference33 articles.

1. Gross, O., Thomas, C. J., Guarda, G. & Tschopp, J. The inflammasome: an integrated view. Immunol. Rev. 243, 136–151 (2011).

2. Kotas, M. E. & Medzhitov, R. Homeostasis, inflammation, and disease susceptibility. Cell 160, 816–827 (2015).

3. Karin, M. & Clevers, H. Reparative inflammation takes charge of tissue regeneration. Nature 529, 307–315 (2016).

4. Zhong, Z., Sanchez-Lopez, E. & Karin, M. Autophagy, inflammation, and immunity: a troika governing cancer and its treatment. Cell 166, 288–298 (2016).

5. Lu, A. et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 156, 1193–1206 (2014).

Cited by 803 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Morphine induces inflammatory responses via both TLR4 and cGAS-STING signaling pathways;Cytokine;2024-11

2. AdipoRon exerts an antidepressant effect by inhibiting NLRP3 inflammasome activation in microglia via promoting mitophagy;International Immunopharmacology;2024-11

3. Bergapten attenuates hemorrhagic shock induced multi-organ injury by inhibiting NLRP3 inflammasome activation and pyroptosis;International Immunopharmacology;2024-10

4. Pathophysiological role and potential drug target of NLRP3 inflammasome in the metabolic disorders;Cellular Signalling;2024-10

5. Potential Impact of Bioactive Compounds as NLRP3 Inflammasome Inhibitors: An Update;Current Pharmaceutical Biotechnology;2024-10